CoChat

Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis

Open access
Welton, Joanne L., Loveless, Samantha, Stone, Timothy, von Ruhland, Chris, Robertson, Neil P., Clayton, Aled · 2017 · Journal of Extracellular Vesicles
Cited by 142

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The discovery of disease biomarkers, along with the use of “liquid biopsies” as a minimally invasive source of biomarkers, continues to be of great interest. In inflammatory diseases of the central nervous system (CNS), cerebrospinal fluid (CSF) is the most obvious biofluid source. Extracellular vesicles (EVs) are also present in CSF and are thought to be potential “biomarker treasure chests”. However, isolating these CSF‐derived EVs remains challenging. This small‐scale pilot study developed and tested a protocol to enrich for CSF‐EVs, both in relapsing remitting multiple sclerosis (RRMS) CSF and controls. These were subsequently compared, using an aptamer based proteomics array, SOMAscan™. EVs were enriched from RRMS patient (n = 4) and non‐demyelinating control (idiopathic intracranial hypertension (IIH) (n = 3)) CSF using precipitation and mini size‐exclusion chromatography (SEC). EV‐enriched fractions were selected using pre‐defined EV characteristics, including increased levels of tetraspanins. EVs and paired CSF were analysed by SOMAscan™, providing relative abundance data for 1128 proteins. CSF‐EVs were characterised, revealing exosome‐like features: rich in tetraspanins CD9 and CD81, size ~100 nm, and exosome‐like morphology by TEM. Sufficient quantities of, SOMAscan™ compatible, EV material was obtained from 5 ml CSF for proteomics analysis. Overall, 348 and 580 proteins were identified in CSF‐EVs and CSF, respectively, of which 50 were found to be significantly (t‐test) and exclusively enriched in RRMS CSF‐EVs. Selected proteins, Plasma kallikrein and Apolipoprotein‐E4, were further validated by western blot and appeared increased in CSF‐EVs compared to CSF. Functional enrichment analysis of the 50 enriched proteins revealed strong associations with biological processes relating to MS pathology and also extracellular regions, consistent with EV enrichment. This pilot study demonstrates practicality for EV enrichment in CSF derived from patients with MS and controls, allowing detailed analysis of protein profiles that may offer opportunities to identify novel biomarkers and therapeutic approaches in CNS inflammatory diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/20013078.2017.1369805

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 142

Metadata

Authors
Welton, J. L., Loveless, S., Stone, T., von Ruhland, C., Robertson, N. P., & Clayton, A.
Venue
Journal of Extracellular Vesicles
Publisher
Wiley
Published
2017-12
Volume
6
Issue
1
Pages
1369805-1369805
ISSN
2001-3078 (ISSN-L)
OpenAlex
W2752823190
Cited by
142
References
7
FWCI
4.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis. https://app.cochat.ai/papers/10.1080/20013078.2017.1369805
The paper
Welton, J. L., Loveless, S., Stone, T., von Ruhland, C., Robertson, N. P., & Clayton, A. (2017). Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis. Journal of Extracellular Vesicles. https://doi.org/10.1080/20013078.2017.1369805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.